(1) Biedert P, Fischl R. Über die Behandlung und Medication bei Kindern im Allge-meinen. In: Fischl R, editor. Lehrbuch der Kinderkrankheiten. 12.th ed. Stuttgart:
Enke; 1902. p. 28-33.
(2) Kulbe A. Grundwissen Psychologie, Soziologie und Pädagogik: Lehrbuch für Pflegeberufe. 3.th ed. Stuttgart: Kohlhammer Verlag; 2017.
(3) IASP Task Force on Taxonomy edited by Merskey,H., Bogduk N. Part III: Pain Terms, A Current List with Definitions and Notes on Usage. In: IASP Press S, edi-tor. Classification of chronic pain. 2.th ed.; 1994. p. 209-214.
(4) McCaffery M, Ferrell BR. Pain and Placebos: Ethical and Professional Issues.
Orthopaedic Nursing 1997;16(5).
(5) Gottschling S. Schmerz bei Kindern. Mythen und Fakten. Angewandte Schmerztherapie und Palliativmedizin 2009(3):59-62.
(6) Michel MZ, Sanders MK, Dolin SJ, Cashman J. Effectiveness of acute postope-rative pain management. BJA: British Journal of Anaesthesia 2003
09/01;91(3):448-449.
(7) Kendlbacher E, Deufert D, Kreyer C, Fritz E. Schmerzprävalenz und
Schmerzintensität bei Kindern und Jugendlichen in einem österreichischen Kran-kenhaus. ProCare 2010 10/01;15(8):9-14.
(8) Walker SM. Pain in children: recent advances and ongoing challenges. BJA:
British Journal of Anaesthesia 2008 07/01;101(1):101-110.
(9) Hicks C, von Baeyer C, Spafford P, van Korlaar I, Goodenough B. The Faces Pain Scale – Revised: toward a common metric in pediatric pain measurement.
Pain 2001 8;93(2):173-183.
(10) Jaksch W, Messerer B, Baumgart H, Breschan C, Fasching G, Grögl G, et al.
Österreichische interdisziplinäre Handlungsempfehlungen zum perioperativen Schmerzmanagement bei Kindern. Der Schmerz 2014;28(1):7-13.
(11) Seyberth H. Prinzipien der Pharmakotherapie und Konzepte der Interaktion.
In: Hoffmann, G.F., Lentze, M.J., Spranger, J., Zepp, F., editor. Pädiatrie
Grundlagen und Praxis. 4.th ed. Berlin Heidelberg: Springer; 2014. p. 1003-1018.
(12) Mayrhofer M. „Off label use“ von Analgetika in der perioperativen Kinder-schmerztherapie aus rechtlicher Sicht. Der Schmerz 2014 02/01;28(1):65-66.
(13) Taxis K, Barber N. Incidence and severity of intravenous drug errors in a Ger-man hospital. Eur J Clin Pharmacol 2004 01/01;59(11):815-817.
(14) Messlinger K, Handwerker HO. Physiologie des Schmerzes. Der Schmerz 2015 10/01;29(5):522-530.
(15) Silbernagl S, Despoupolos A. Taschenatlas Physiologie. 8th ed. Stuttgart:
Thieme; 2012.
(16) Woolf CJ, Salter MW. Neuronal Plasticity: Increasing the Gain in Pain. Sci-ence 2000 06/09;288(5472):1765.
(17) Melzack R, Wall PD. Pain Mechanisms: A New Theory. Science 1965 11/19;150(3699):971.
(18) Mendell LM. Constructing and Deconstructing the Gate Theory of Pain. Pain 2013 12/12;155(2):210-216.
(19) Schaible H, Schmidt R. Discharge characteristics of receptors with fine affer-ents from normal and inflamed joints: influence of analgesics and prostaglandins.
Agents and actions.Supplements 1986;19:99-117.
(20) Zernikow B. Schmerztherapie bei Kindern, Jugendlichen und jungen Erwach-senen. 4. Auflage ed. Heidelberg: Springer Medizin Verlag; 2009.
(21) Simons SHP, Tibboel D. Pain perception development and maturation. Semi-nars in Fetal and Neonatal Medicine 2017/09;11(4):227-231.
(22) Humphrey T. Some Correlations between the Appearance of Human Fetal Reflexes and the Development of the Nervous System. Prog Brain Res 1964 1964;4(Supplement C):93-135.
(23) Pattinson D, Fitzgerald M. The Neurobiology of Infant Pain: Development of Excitatory and Inhibitory Neurotransmission in the Spinal Dorsal Horn. ; 2004.
(24) Tilney, F., Rosett, J. The value of brain lipoids as an index of brain develop-ment. Bull Neurol Inst NY 1931(1):28-71.
(25) Jennings E, Fitzgerald M. Postnatal changes in responses of rat dorsal horn cells to afferent stimulation: a fibre-induced sensitization. J Physiol (Lond ) 1998 02/19;509:859-868.
(26) Cordero-Erausquin M, Coull JAM, Boudreau D, Rolland M, Koninck YD. Dif-ferential Maturation of GABA Action and Anion Reversal Potential in Spinal Lam-ina I Neurons: Impact of Chloride Extrusion Capacity. J Neurosci 2005
10/19;25(42):9613.
(27) Bremner LR, Fitzgerald M. Postnatal tuning of cutaneous inhibitory receptive fields in the rat. J Physiol (Lond ) 2007 12/06;586:1529-1537.
(28) van Praag H, Frenk H. The development of stimulation-produced analgesia (SPA) in the rat. Developmental Brain Research 1991 17 December
1991;64(1):71-76.
(29) Fitzgerald M. The development of nociceptive circuits. Nat Rev Neurosci 2005 print;6(7):507-520.
(30) Kesavan K. Neurodevelopmental Implications of Neonatal Pain an Morphine Exposure. Pediatr Ann 2015(44):260-261.
(31) Ranger M, Chau CMY, Garg A, Woodward TS, Beg MF, Bjornson B, et al.
Neonatal Pain-Related Stress Predicts Cortical Thickness at Age 7 Years in Chil-dren Born Very Preterm. PLoS ONE 2013 08/25;8(10):e76702.
(32) Bouwmeester NJ, Anderson BJ, Tibboel D, Holford NHG. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. BJA: British Journal of Anaesthesia 2004 02/01;92(2):208-217.
(33) Olkkola KT, Hamunen K, Maunuksela E. Clinical Pharmacokinetics and Phar-macodynamics of Opioid Analgesics in Infants and Children. Clin Pharmacokinet 1995 05/01;28(5):385-404.
(34) Anand P, Birch R. Restoration of sensory function and lack of long‐term chronic pain syndromes after brachial plexus injury in human neonates. Brain 2002 01/01;125(1):113-122.
(35) McCann ME, Waters P, Goumnerova LC, Berde C. Self-mutilation in young children following brachial plexus birth injury. Pain 2004 July 2004;110(1):123-129.
(36) Taddio A, Katz J. The Effects of Early Pain Experience in Neonates on Pain Responses in Infancy and Childhood. Pediatric Drugs 2005 07/01;7(4):245-257.
(37) Taddio A, Goldbach M, Ipp M, Stevens B, Koren G. Effect of neonatal circum-cision on pain responses during vaccination in boys. The Lancet
2017/10;345(8945):291-292.
(38) Eckstein Grunau R. Early pain in preterm infants: A model of long-term ef-fects. Clin Perinatol 2002 9;29(3):373-394.
(39) Anand KJ. Neonatal stress responses to anesthesia and surgery. Clin Perina-tol 1990 03;17(1):207-214.
(40) Brummelte S, Grunau RE, Chau V, Poskitt KJ, Brant R, Vinall J, et al. Proce-dural pain and brain development in premature newborns. Ann Neurol 2012 02/28;71(3):385-396.
(41) Peters JWB, Schouw R, Anand KJS, van Dijk M, Duivenvoorden HJ, Tibboel D. Does neonatal surgery lead to increased pain sensitivity in later childhood?
Pain 2005;114(3).
(42) Chiaretti A, Pierri F, Valentini P, Russo I, Gargiullo L, Riccardi R. Current practice and recent advances in pediatric pain management. Eur Rev Med Phar-macol Sci 2013;17(1):112-126.
(43) Messerer B, Sandner-Kiesling A. Organisation des Schmerzmanagements bei Kindern. Der Schmerz 2014 02/01;28(1):14-24.
(44) Schimpf JC, D., Sollmann V. Perioperative Schmerztherapie. Kompendium
(45) Aktories K, Förstermann U, Hofmann F, Starke K. Allgemeine und spezielle Pharmakologie und Toxikologie
Begründet von W. Forth, D. Henschler, W. Rummel. 11.th ed. München: Ur-ban&Fischer; 2013.
(46) Kart T, Christrup L, Rasmussen M. Recommended use of morphine in neo-nates, infants and children based on a literature review: Part 1—Pharmacokinet-ics. Pediatric Anesthesia 1997;7(1):5-11.
(47) Jöhr M. Kinderanästhesie. 8.th ed. München: Urban & Fischer Verlag/Elsevier GmbH; 2013.
(48) Hall RW, Anand KJS. Pain Management in Newborns. Clin Perinatol 2014 10/07;41(4):895-924.
(49) Messerer B, Sandner-Kiesling A. Schmerztherapie an einer zertifizierten Kli-nik für Kinderchirurgie. Monatsschrift Kinderheilkunde 2014 01/01;162(1):26-36.
(50) Rømsing J, Møiniche S, Dahl JB. Rectal and parenteral paracetamol, and pa-racetamol in combination with NSAIDs, for postoperative analgesia. BJA: British Journal of Anaesthesia 2002 02/01;88(2):215-226.
(51) Wong I, St John-Green C, Walker SM. Opioid-sparing effects of perioperative paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs) in children. Pae-diatr Anaesth 2013 03/04;23(6):475-495.
(52) Messerer B, Grögl G, Stromer W, Jaksch W. Perioperative systemische Schmerztherapie bei Kindern. Der Schmerz 2014 02/01;28(1):43-64.
(53) Lewis S, Nicholson A, Cardwell M, Siviter G, Smith A. Nonsteroidal anti-in-flammatory drugs and perioperative bleeding in paediatric tonsillectomy. - Cochrane Database of Systematic Reviews (7).
(54) Thiel H, Roewer N. Anästhesiologische Pharmakotherapie
Von den Grundlagen der Pharmakologie zur Medikamentenpraxis. 3.th ed.
Stuttgart: Thieme; 2014.
(55) Levy M, Zylber-Katz E, Rosenkranz B. Clinical Pharmacokinetics of Dipyrone and its Metabolites. Clin Pharmacokinet 1995 03/01;28(3):216-234.
(56) Meyer O, Gaedicke G, Salama A. Demonstration of drug-dependent antibod-ies in two patients with neutrophenia and successful treatment with granulocyte–
colony-stimulating factor. Transfusion 1999;39(5):527-530.
(57) Howard CR, Weitzman ML, Howard FM. Acetaminophen Analgesia in Neona-tal Circumcision: The Effect on Pain. Pediatrics 1994 04/01;93(4):641.
(58) van Ganzewinkel C, Derijks L, Anand K, van Lingen R, Neef C, Kramer B, et al. Multiple intravenous doses of paracetamol result in a predictable pharmacoki-netic profile in very preterm infants. Acta Paediatrica 2014;103(6):612-617.
(59) Magnus MC, Karlstad Ã, HÃ¥berg S,E., Nafstad P, Davey Smith G, Nystad W. Prenatal and infant paracetamol exposure and development of asthma: the Norwegian Mother and Child Cohort Study. Int J Epidemiol 2016 04/01;45(2):512-522.
(60) von Mutius E, Gappa M, Eber E, Frey U. Pädiatrische Pneumologie. 3.th ed.
Berlin Heidelberg: Springer; 2013.
(61) Kang EM, Lundsberg LS, Illuzzi JL, Bracken MB. Prenatal Exposure to Aceta-minophen and Asthma in Children. Obstet Gynecol 2009 12;114(6):1295-1306.
(62) Sheehan WJ, Mauger DT, Paul IM, Moy JN, Boehmer SJ, Szefler SJ, et al.
Acetaminophen versus Ibuprofen in Young Children with Mild Persistent Asthma.
N Engl J Med 2016 08/18;375(7):619-630.
(63) Zeeck A, Grond, S., Zeeck, S.C. Chemie für Mediziner. 9th ed. München: Ur-ban &Fischer/Elsevier; 2017.
(64) Acharya A, Annamali S, Taub N, Field D. Oral sucrose analgesia for preterm infant venepuncture. Archives of Disease in Childhood Fetal and Neonatal Edition 2004 01;89(1):F17-F18.
(65) Abad F, Diaz N, Domenech E, Robayna M, Rico J. Oral sweet solution re-duces pain-related behaviour in preterm infants. Acta Pædiatrica 1996;85(7):854-858.
(66) Matsuda E. Sucrose as Analgesia in Neonates Undergoing Painful Proce-dures. AJN The American Journal of Nursing 2017;117(8).
(67) Yamamoto T, Sako N, Maeda S. Effects of taste stimulation on β-endorphin levels in rat cerebrospinal fluid and plasma. Physiology & Behavior 2000 May 2000;69(3):345-350.
(68) Linakis MW, Roberts JK, Lala AC, Spigarelli MG, Medlicott NJ, Reith DM, et al. Challenges Associated with Route of Administration in Neonatal Drug Delivery.
Clin Pharmacokinet 2016 02/01;55(2):185-196.
(69) Kretz F, Becke K. Anästhesie und Intensivmedizin bei Kindern. 2.th ed.
Stuttgart: Thieme; 2007.
(70) Breitkreutz J, Boos J. Drug Delivery and Formulations. In: Seyberth H, Rane A, Schwab M, editors. Pediatric Clinical Pharmacology. Handbook of Experimental Pharmacology, vol 205. 1st ed. Berlin Heidelberg: Springer; 2011. p. 91-107.
(71) Strolin Benedetti M, Whomsley R, Baltes EL. Differences in absorption, distri-bution, metabolism and excretion of xenobiotics between the paediatric and adult populations. Expert Opinion on Drug Metabolism & Toxicology 2005
10/01;1(3):447-471.
(72) Strolin Benedetti M, Baltes EL. Drug metabolism and disposition in children.
Fundam Clin Pharmacol 2003;17(3):281-299.
(73) Bartelink IH, Rademaker CM, Schobben AF, van den Anker, John N. Guide-lines on paediatric dosing on the basis of developmental physiology and pharma-cokinetic considerations. Clin Pharmacokinet 2006;45(11):1077-1097.
(74) Kearns GL, Abdel-Rahman S, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental Pharmacology — Drug Disposition, Action, and Therapy in In-fants and Children. N Engl J Med 2003 09/18; 2017/11;349(12):1157-1167.
(75) Batchelor HK, Marriott JF. Paediatric pharmacokinetics: key considerations.
Br J Clin Pharmacol 2013 10/17;79(3):395-404.
(76) Rodeck B, Zimmer K-. Pädiatrische Gastroenterologie, Hepatologie und Er-nährung. 2nd ed. Berlin Heidelberg: Springer-Verlag; 2013.
(77) Seyberth HW, Kauffman RE. Basics and Dynamics of Neonatal and Pediatric Pharmacology. In: Seyberth HW, Rane A, Schwab M, editors. Pediatric Clinical Pharmacology Berlin, Heidelberg: Springer Berlin Heidelberg; 2011. p. 3-49.
(78) Besunder JB, Reed MD, Blumer JL. Principles of Drug Biodisposition in the Neonate. Clin Pharmacokinet 1988 05/01;14(5):261-286.
(79) Allegaert K, van dV, van dA. Neonatal clinical pharmacology. Paediatr Anaesth 2013 04/26;24(1):10.1111/pan.12176.
(80) Radde IC. MH. Transport through membranes and development of mem-branes. In: McLeod SM. RI, editor. Textbook of Pediatric Clinical Pharmacology.
1.th ed. Littleton, MA: PSG Publishing Company; 1985. p. 1-16.
(81) Bundesamt für Sicherheit im Gesundheitswesen. Arzneimittelspezialitätenre-gister, Wirkstoff: Morphin. 13.10.2017; Available at: https://aspregister.basg.gv.at, 10/2017.
(82) Meuldermans WEG, Hurkmans RMA, Heykants JJP. Plasma protein binding and distribution of fentanyl, sufentanil, alfentanil and lofentanil in blood. ; 1982.
(83) Bundesamt für Sicherheit im Gesundheitswesen. Arzneimittelspezialitätenre-gister, Wirkstoff: Fentanyl. 13.10.2017; Available at: https://aspregister.basg.gv.at, 10/2017.
(84) Bundesamt für Sicherheit im Gesundheitswesen. Arzneimittelspezialitätenre-gister, Wirkstoff: Ibuprofen. 13.10.2017; Available at:
https://aspregis-ter.basg.gv.at, 10/2017.
(85) Bundesamt für Sicherheit im Gesundheitswesen. Arzneimittelspezialitätenre-gister, Wirkstoff: Diclofenac. 13.10.2017; Available at:
https://aspregis-ter.basg.gv.at, 10/2017.
(86) van dM, Anderson BJ, van Lingen RA, Holford NHG, Pluim MAL, Jansman FGA, et al. Paracetamol and metabolite pharmacokinetics in infants. Eur J Clin Pharmacol 2003 07/01;59(3):243-251.
(87) Bundesamt für Sicherheit im Gesundheitswesen. Arzneimittelspezialitätenre-gister, Wirkstoff: Metamizol. 13.10.2017; Available at:
https://aspregis-ter.basg.gv.at, 10/2017.
(88) Marzuillo P, Guarino S, Barbi E. Paracetamol: a focus for the general pediatri-cian. Eur J Pediatr 2014 04/01;173(4):415-425.
(89) Bundesamt für Sicherheit im Gesundheitswesen. Arzneimittelspezialitätenre-gister, Wirkstoff: Paracetamol. 13.10.2017; Available at:
https://aspregis-ter.basg.gv.at, 10/2017.
(90) Kearns GL, Reed MD. Clinical Pharmacokinetics in Infants and Children. Clin Pharmacokinet 1989 12/01;17(1):29-67.
(91) Osthaus W, Ankermann T, Sümpelmann R. Präklinische Flüssigkeitstherapie im Kindesalter
. Pädiatrie up2date 2013(01):67-84.
(92) Allegaert K, Van der Marel,C.D., Debeer A, Pluim M, Van Lingen,R.A.,
Vanhole C, et al. Pharmacokinetics of single dose intravenous propacetamol in ne-onates: effect of gestational age. Archives of Disease in Childhood Fetal and Neo-natal Edition 2004 01;89(1):F25-F28.
(93) Waters CM, Avram MJ, Krejcie TC, Henthorn TK. Uptake of Fentanyl in Pul-monary Endothelium. J Pharmacol Exp Ther 1999 01/01;288(1):157.
(94) Waldvogel HH. Analgetika Antinozizeptiva Adjuvanzien
Handbuch für die Schmerzpraxis. 2.th ed. Heidelberg: Springer; 2001.
(95) Forrest JAH, Clements JA, Prescott LF. Clinical Pharmacokinetics of Parace-tamol. Clin Pharmacokinet 1982 04/01;7(2):93-107.
(96) Gäbler RP. Analgesia in neonates, infants and toddlers. Anästh Intensivmed 2008(49):407-418.
(97) Hines RN. The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacology & Therapeutics 2008 May 2008;118(2):250-267.
(98) Blake MJ, Castro L, Leeder JS, Kearns GL. Ontogeny of drug metabolizing enzymes in the neonate. Seminars in Fetal and Neonatal Medicine 2005 April 2005;10(2):123-138.
(99) Mulhall A, de Louvois J, Hurley R. Chloramphenicol toxicity in neonates: its in-cidence and prevention. Br Med J (Clin Res Ed) 1983 11/12;287(6403):1424-1427.
(100) Van Overmeire B, Touw D, Schepens PJC, Kearns GL, van dA. Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clinical Phar-macology & Therapeutics 2001;70(4):336-343.
(101) Tonner P, Hein L editors. Pharmakotherapie in der Anästhesie und
Intensiv-(102) van dA, de Groot R, Broerse HM, Sauer PJJ, van dH, Hop WCJ, et al. As-sessment of Glomerular Filtration Rate in Preterm Infants by Serum Creatinine:
Comparison With Inulin Clearance. Pediatrics 1995 12/01;96(6):1156.
(103) Jong G‘. Pediatric Development: Physiology. Enzymes, Drug Metabolism, Pharmacokinetics and Pharmacodynamics. In: Bar-Shalom D, Rose K, editors.
Pediatric Formulations: A Roadmap New York, NY: Springer New York; 2014. p.
9-23.
(104) Allegaert K, Cossey V, Debeer A, Langhendries JP, Van Overmeire B, de Hoon J, et al. The impact of ibuprofen on renal clearance in preterm infants is in-dependent of the gestational age. Pediatric Nephrology 2005 06/01;20(6):740-743.
(105) Rossaint R, Werner C, Zwißler B. Allgemeine Anästhesiologie, Schmerzthe-rapie und Intensivmedizin. 3.th ed. Berlin Heidelberg: Springer; 2012.
(106) Baarslag MA, Allegaert K, Van DA, Knibbe CAJ, Van Dijk M, Simons SHP, et al. Paracetamol and morphine for infant and neonatal pain; still a long way to go? Expert Review of Clinical Pharmacology 2017 01/02;10(1):111-126.
(107) Marti E, Gibson SJ, Polak JM, Facer P, Springall DR, van Aswegen G, et al.
Ontogeny of peptide- and amine-containing neurones in motor, sensory, and auto-nomic regions of rat and human spinal cord, dorsal root ganglia, and rat skin. J Comp Neurol 1987;266(3):332-359.
(108) Blass EM, Cramer CP, Fanselow MS. The development of morphine-in-duced antinociception in neonatal rats: A comparison of forepaw, hindpaw, and tail retraction from a thermal stimulus. Pharmacology Biochemistry and Behavior 1993 March 1993;44(3):643-649.
(109) Reynolds ML, Fitzgerald M. Long-term sensory hyperinnervation following neonatal skin wounds. J Comp Neurol 1995;358(4):487-498.